What is the ticker symbol for Caribou Biosciences?

Caribou Biosciences trades under the ticker CRBU on NASDAQ.

What sector does Caribou Biosciences operate in?

Caribou Biosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CRBU in a portfolio?

PortView shows CRBU's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Caribou Biosciences (CRBU) Stock Analysis

NASDAQHealthcareBiotechnology

$1.58+1.94%

1-year price historyRange $1.39 – $2.84

52-week range$1.58

$1.38$3.54

What Caribou Biosciences does

Caribou Biosciences, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to pioneering genome-edited allogeneic cell therapies. These cutting-edge treatments are engineered to address both hematologic malignancies (blood cancers) and solid tumors, serving patients across the United States and internationally. Among its primary therapeutic candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy currently undergoing Phase 1 clinical trials for relapsed or refractory B cell non-Hodgkin lymphoma, and CB-011, an allogeneic anti-BCMA CAR-T cell therapy targeting relapsed or refractory multiple myeloma. Caribou Biosciences is additionally developing CB-012, an allogeneic anti-CD371 CAR-T cell therapy for relapsed or refractory acute myeloid leukemia, along with CB-020, an allogeneic CAR-NK cell therapy aimed at solid tumors. The company also maintains a collaborative agreement with AbbVie Manufacturing Management Unlimited Company for the joint advancement of CAR-T cell therapies. Founded in 2011, Caribou Biosciences' headquarters are located in Berkeley, California.

Key metrics

Market cap

$156.71M

P/E (TTM)

-1.46

EPS (TTM)

$-1.08

Beta

2.28

Dividend yield

0.00%

Revenue / share

$0.10

50-day avg

$1.66

200-day avg

$1.80

52-week high

$3.54

52-week low

$1.38

CEO

Rachel E. Haurwitz

ETFs linked to CRBU

Broad-market and Healthcare sector ETFs an investor holding Caribou Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CRBU fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CRBU in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Caribou Biosciences?: Caribou Biosciences trades under the ticker CRBU on NASDAQ.
Which exchange is CRBU listed on?: CRBU is listed on NASDAQ.
What sector does Caribou Biosciences operate in?: Caribou Biosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CRBU in a portfolio?: PortView shows CRBU's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.